These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 904946)

  • 41. [Non-dialyzable beta-glucuronidase inhibitor in guinea-pig urine. I. Purification (author's transl)].
    Kaizu T
    Yakugaku Zasshi; 1975 Oct; 95(10):1226-33. PubMed ID: 1238533
    [No Abstract]   [Full Text] [Related]  

  • 42. Exposure to toluene increases the urinary excretion of D-glucaric acid.
    Moretto A; Lotti M
    Br J Ind Med; 1990 Jan; 47(1):58-61. PubMed ID: 2310708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Indocyanine green kinetics in newborns with non-hemolytic hyperbilirubinemia (author's transl)].
    Heimann G; Roth B; Gladtke E
    Klin Wochenschr; 1977 May; 55(9):451-6. PubMed ID: 875318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Phenobarbital in the treatment of hyperbilirubinemia of the newborn].
    Cao A; Fracassini F; Falorni A; Mastrantonio P
    Pediatria (Napoli); 1969; 77(1):177-88. PubMed ID: 5404931
    [No Abstract]   [Full Text] [Related]  

  • 45. [The influence of a short-time enzyme induction with phenobarbital on hyperbilirubinemia in premature newborns].
    Zwacka G; Frenzel J
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2230-4. PubMed ID: 5487509
    [No Abstract]   [Full Text] [Related]  

  • 46. [Urinary secretion of D-glucaric acid in subjects exposed to styrene].
    Loi AM; Biagini AM; Paggiaro PL; Roselli MG; Cristaudo A; Bertone C; Ricco U; Fontana V; Rossi G; Baschieri L
    Med Lav; 1984; 75(2):110-4. PubMed ID: 6749047
    [No Abstract]   [Full Text] [Related]  

  • 47. Negative feedback control of neonatal serum creatine and increased urinary creatinine excretion after enzyme-inducing drugs.
    Talafant E; Hosková A; Pojerová A
    Pediatr Res; 1977 Aug; 11(8):880-3. PubMed ID: 887306
    [No Abstract]   [Full Text] [Related]  

  • 48. The course of hyperbilirubinemia in the very low birth weight infant treated with phenobarbital.
    Anwar M; Valdivieso J; Hiatt IM; Hegyi T
    J Perinatol; 1987; 7(2):145-8. PubMed ID: 3505611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucaric acid excretion. Analysis of the enzymatic assay and findings in smokers and non-smokers.
    Fiedler K; Schröter E; Cramer H
    Eur J Clin Pharmacol; 1980 Nov; 18(5):429-32. PubMed ID: 7439267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Behavior of urinary D-glucaric acid in occupational exposure to inorganic lead].
    Apostoli P; Romeo L; Ferioli A; Ferrari S; Pasini F
    Med Lav; 1987; 78(5):372-9. PubMed ID: 3447026
    [No Abstract]   [Full Text] [Related]  

  • 51. [The effect of contraceptives on serum lipids, gamma glutamyl transpeptidase and D-glucaric acid elimination].
    Berlin I; Hajós P; Intödy Z; Tornyossy M; Káldor A
    Orv Hetil; 1980 Oct; 121(42):2577. PubMed ID: 6110202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A semiautomated procedure for urinary D-glucaric acid using a centrifugal analyzer.
    MacNeil ML; Steinberg KK; Yeager PR; Smith SJ
    J Anal Toxicol; 1986; 10(1):15-7. PubMed ID: 3951202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of corticosteroid treatment on bilirubin metabolism in chronic aggressive hepatitis.
    Kawasaki H; Ogata T; Irisa T; Hirayama C
    Acta Hepatogastroenterol (Stuttg); 1977 Jun; 24(3):175-81. PubMed ID: 883466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
    Rost KL; Mansmann U; Roots I
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):14-8. PubMed ID: 9021436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between the level of urinary D-glucaric acid and the degree of activation of masked compound (FT-207) in cancer patients.
    Matsuoka S; Maezawa S; Sakuma M; Ohira S; Wakui A; Saito T
    Tohoku J Exp Med; 1981 Nov; 135(3):281-90. PubMed ID: 6797104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hyperbilirubinemia in full-term newborns. Predictive factors].
    Carbonell Estrany X; Botet Mussons F; Figueras Aloy J; Riu Godó A
    An Esp Pediatr; 1999 Apr; 50(4):389-92. PubMed ID: 10356833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Responsiveness to phenobarbital in an adult with Crigler-Najjar disease associated with neurological involvement and skin hyperextensibility.
    Persico M; Romano M; Muraca M; Gentile S
    Hepatology; 1991 Feb; 13(2):213-5. PubMed ID: 1899849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies.
    Epstein MF; Leviton A; Kuban KC; Pagano M; Meltzer C; Skouteli HN; Brown ER; Sullivan KF
    Pediatrics; 1988 Sep; 82(3):350-4. PubMed ID: 3405664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary excretion of D-glucaric acid in porphyria cutanea tarda.
    Tutor JC; Lopez-Urrutia A; Fernandez MP
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):855-8. PubMed ID: 2895161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
    Buchanan N; Eyberg C; Davis MD
    Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.